GUGLIELMI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 4.465
AS - Asia 1.788
EU - Europa 1.292
SA - Sud America 232
AF - Africa 99
OC - Oceania 8
Totale 7.884
Nazione #
US - Stati Uniti d'America 4.337
IT - Italia 712
SG - Singapore 564
CN - Cina 285
HK - Hong Kong 283
VN - Vietnam 234
IN - India 209
BR - Brasile 177
DE - Germania 125
CA - Canada 96
FR - Francia 94
GB - Regno Unito 73
SE - Svezia 67
FI - Finlandia 52
ZA - Sudafrica 50
RU - Federazione Russa 44
JP - Giappone 40
BD - Bangladesh 34
IE - Irlanda 33
AR - Argentina 26
ID - Indonesia 22
NL - Olanda 20
PK - Pakistan 18
MX - Messico 17
ES - Italia 12
IQ - Iraq 11
MY - Malesia 11
UA - Ucraina 11
TR - Turchia 10
KR - Corea 9
CH - Svizzera 8
CI - Costa d'Avorio 8
EC - Ecuador 8
MA - Marocco 8
TW - Taiwan 8
EG - Egitto 7
PY - Paraguay 7
RO - Romania 7
AT - Austria 6
JO - Giordania 6
PH - Filippine 6
AU - Australia 5
AZ - Azerbaigian 5
BG - Bulgaria 5
TG - Togo 5
CL - Cile 4
GR - Grecia 4
JM - Giamaica 4
KE - Kenya 4
KZ - Kazakistan 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
GH - Ghana 3
NP - Nepal 3
PL - Polonia 3
SN - Senegal 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
BO - Bolivia 2
BY - Bielorussia 2
CO - Colombia 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
LB - Libano 2
LT - Lituania 2
MU - Mauritius 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
OM - Oman 2
ZM - Zambia 2
AL - Albania 1
AS - Samoa Americane 1
BB - Barbados 1
BZ - Belize 1
CY - Cipro 1
DK - Danimarca 1
GD - Grenada 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
NI - Nicaragua 1
PA - Panama 1
PS - Palestinian Territory 1
QA - Qatar 1
SO - Somalia 1
SR - Suriname 1
SV - El Salvador 1
UY - Uruguay 1
Totale 7.884
Città #
Ashburn 613
Rome 359
Singapore 295
Fairfield 269
Hong Kong 260
San Jose 255
Dallas 201
Los Angeles 173
New York 163
Houston 138
Seattle 113
Woodbridge 113
Santa Clara 100
Chandler 86
Wilmington 85
Cambridge 79
Beijing 71
Ho Chi Minh City 69
Hanoi 61
Denver 58
Council Bluffs 56
Chicago 51
San Francisco 51
Munich 50
Orem 44
Ann Arbor 40
Lauterbourg 40
Princeton 40
The Dalles 37
Brooklyn 36
Johannesburg 36
Buffalo 35
San Paolo di Civitate 34
Phoenix 33
Atlanta 32
Boston 32
Dublin 32
Frankfurt am Main 32
Latina Scalo 31
Lawrence 28
Tokyo 28
Hillsboro 27
Montreal 25
Toronto 24
Helsinki 23
Redondo Beach 22
San Diego 21
Jakarta 19
Washington 19
Milan 17
Millbury 17
Bengaluru 16
London 16
Plano 16
Dearborn 15
Moscow 15
Turku 15
Da Nang 12
Hefei 12
Mumbai 12
São Paulo 12
Ottawa 11
Tampa 11
Andover 10
Calgary 10
Falkenstein 10
Pessac 10
Canary Wharf 9
Haiphong 9
Hyderabad 9
Lappeenranta 9
Philadelphia 9
Abidjan 8
Guangzhou 8
Las Vegas 8
Ludhiana 8
Norwalk 8
Providence 8
Salt Lake City 8
Stockholm 8
Chennai 7
Cleveland 7
Islamabad 7
Lancaster 7
Miami 7
Naples 7
Seoul 7
Thái Nguyên 7
Wuhan 7
Cagliari 6
Hải Dương 6
Istanbul 6
Lahore 6
Paris 6
Queens 6
Raleigh 6
Redwood City 6
Shanghai 6
Zurich 6
Baku 5
Totale 5.013
Nome #
The up-regulation of oxidative stress as a potential mechanism of novel MAO-B inhibitors for glioblastoma treatment 1.081
Open saccharin-based secondary sulfonamides as potent and selective inhibitors of cancer-related carbonic anhydrase IX and XII isoforms 897
Design, synthesis and biochemical evaluation of novel multi-target inhibitors as potential anti-Parkinson agents 187
Benzo[b]tiophen-3-ol derivatives as effective inhibitors of human monoamine oxidase: design, synthesis, and biological activity 186
Synthesis and biological evaluation of new saccharin-based inhibitors of cancer-related carbonic anhydrase IX and XII isoforms & Benzo[b]tiophen-3-ol derivatives as effective inhibitors of hMAOs: design, synthesis and biological activity 178
Design, synthesis and biological activity of selective hCAs inhibitors based on 2-(benzylsulfinyl)benzoic acid scaffold 168
A novel library of saccharin and acesulfame derivatives as potent and selective inhibitors of carbonic anhydrase IX and XII isoforms 166
Novel therapies for glaucoma: a patent review (2013-2019) 166
4-(3-Nitrophenyl)thiazol-2-ylhydrazone derivatives as antioxidants and selective hMAO-B inhibitors: synthesis, biological activity and computational analysis 163
Natural compounds and extracts as novel antimicrobial agents 162
Design, synthesis, docking studies and monoamine oxidase inhibition of a small library of 1-acetyl- and 1-thiocarbamoyl-3,5-diphenyl-4,5-dihydro-(1h)-pyrazoles 157
Synthesis and pharmacological screening of a large library of 1,3,4-thiadiazolines as innovative therapeutic tools for the treatment of prostate cancer and melanoma 156
Novel insights on human carbonic anhydrase inhibitors based on coumalic acid. Design, synthesis, molecular modeling investigation, and biological studies 156
Inhibition of human monoamine oxidase: biological and molecular modeling studies on selected natural flavonoids 153
Antimalarial agents from medicinal plant and fungal sources 152
Design, synthesis, molecular modelling investigation and biological studies of novel human carbonic anhydrase inhibitors based on coumalic acid 150
Synthesis and biological evaluation of anti-Toxoplasma gondii activity of a novel scaffold of thiazolidinone derivatives 150
Magnetic metal−organic framework composite by fast and facile mechanochemical process 148
Analysis of imidazoles and triazoles in biological samples after MicroExtraction by packed sorbent 142
1,3-Dipolar Cycloaddition, HPLC Enantioseparation, and Docking Studies of Saccharin/Isoxazole and Saccharin/Isoxazoline Derivatives as Selective Carbonic Anhydrase IX and XII Inhibitors 131
Enantiomers of triclabendazole sulfoxide: analytical and semipreparative HPLC separation, absolute configuration assignment, and transformation into sodium salt 130
Crystal structure of the Eg5 - K858 complex and implications for structure-based design of thiadiazole-containing inhibitors 130
High-performance liquid chromatography enantioseparation of chiral 2-(benzylsulfinyl)benzamide derivatives on cellulose tris(3,5-dichlorophenylcarbamate) chiral stationary phase 130
Novel approaches to the discovery of selective human monoamine oxidase-B inhibitors: is there room for improvement? 130
Novel insights on saccharin- and acesulfame-based carbonic anhydrase inhibitors: design, synthesis, modelling investigations and biological activity evaluation 127
Synthesis and evaluation of thymol-based synthetic derivatives as dual-action inhibitors against different strains of h. pylori and AGS cell line 127
Metal-organic frameworks (MOFs) as biomolecules drug delivery systems for anticancer purposes 126
Protective effects Induced by microwave-assisted aqueous harpagophytum extract on rat cortex synaptosomes challenged with amyloid β-peptide 123
Kinesin Eg5 targeting inhibitors as a new strategy for gastric adenocarcinoma treatment 121
Synthesis and evaluation of a large library of nitroxoline derivatives as pancreatic cancer antiproliferative agents 121
Chalcones: Unearthing their therapeutic possibility as monoamine oxidase B inhibitors 118
The sodium salt of the enantiomers of ricobendazole: preparation, solubility and chiroptical properties 112
Chiral hydroxy metabolite of Mebendazole. Analytical and semi-preparative high-performance liquid chromatography resolution and chiroptical properties 110
Synthesis and biological evaluation of carvacrol-based derivatives as dual inhibitors of H. Pylori strains and ags cell proliferation 108
Dual carbonic anhydrase ix/xii inhibitors and carbon monoxide releasing molecules modulate LPS-mediated inflammation in mouse macrophages 107
An updated patent review on monoamine oxidase (MAO) inhibitors 102
Drug design and synthesis of new anticancer agents 95
A multitarget approach against neuroinflammation. Alkyl substituted coumarins as inhibitors of enzymes involved in neurodegeneration 93
Indoleamine 2,3-dioxygenase 92
Mechanisms of action of carbonic anhydrase inhibitors: compounds that bind “out of the binding site” and compounds with an unknown mechanism of action 89
Novel therapeutic opportunities for Toxoplasma gondii, Trichomonas vaginalis, and Giardia intestinalis infections 88
Treatment of Toxoplasmosis: An Insight on Epigenetic Drugs 83
Kinetic study on the base-catalyzed imine-enamine tautomerism of a chiral biologically active isoxazoline derivative by HPLC on Amylose Tris(3,5-dimethylphenylcarbamate) chiral stationary phase 81
New aspects of monoamine oxidase b inhibitors. The key role of halogens to open the golden door 81
Novel Insights on CAI–CORM hybrids. Evaluation of the CO releasing properties and pain-relieving activity of differently substituted coumarins for the treatment of rheumatoid arthritis 73
Opening new scenarios for human MAO inhibitors 68
Copper(I)-Anchoring Covalent Organic Polymer for Heterogeneous CuAAC Reaction without Reducing Agents and Copper Leaching 61
An innovative spectroscopic approach for qualitative and quantitative evaluation of Mb-CO from myoglobin carbonylation reaction through chemometrics methods 61
Design, synthesis, and biological activity of 2-aroylbenzofuran-3-ols and 2-aroylbenzofuran derivatives. A new route towards hMAO-B inhibition 58
Innovative pH-interfering agents in association with anticancer agents 56
null 54
Aurone Scaffold and Structural Analogues for the Development of Monoamine Oxidase (MAO) Inhibitors 52
In vitro CO-releasing and antioxidant properties of sulfonamide-based CAI-CORMs in a H2O2-stimulated human Achilles tendon-derived cell model 50
Potential of MAO-B Inhibitors with Multi-Target Inhibition and Antioxidant Properties for the Treatment of Neurodegenerative Disorders 42
Azo derivatives of monoterpenes as anti-Helicobacter pylori agents. From synthesis to structure-based target investigation 40
null 36
null 26
null 20
Novel insights on benzo[b]thiophene analogues for MAO-B inhibition and neuroprotection. Design, synthesis, molecular modelling studies and biological activity 11
Patents involving monoamine oxidase (MAO). A comprehensive update (2022–2025) on its inhibitors and applications 7
Totale 8.188
Categoria #
all - tutte 20.399
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.399


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202141 0 0 0 0 0 0 0 0 0 0 35 6
2021/2022464 19 26 28 19 62 7 17 34 35 19 133 65
2022/2023493 86 84 16 53 55 41 28 27 59 4 26 14
2023/2024479 27 42 30 44 37 114 15 25 27 52 32 34
2024/20251.079 26 33 55 58 81 51 54 101 104 93 127 296
2025/20264.486 267 133 248 248 345 142 341 180 294 311 1.977 0
Totale 8.188